MHRA approves semaglutide oral tablets for weight loss The Medicines and Healthcare products Regulatory Agency advises that patients must start at the lowest 1.5mg daily dose of oral semaglutide tablets, which can be further increased to 4mg, 9mg and 25mg doses.…
First health security risk assessment highlights risk of respiratory pandemic and AMR The UK Health Security Agency said that the risk of respiratory infections with pandemic potential was ranked the highest owing to “high impact and likelihood, and repeated historical precedence”.…
NICE approves atogepant for use during migraine attack Atogepant has been approved for patients who have tried at least two triptans, non-steroidal anti-inflammatory drugs and paracetamol for acute migraines, but they did not work well enough.…
Case-based learning: stimulant-induced psychosis associated with ADHD pharmacotherapy Diagnosis and management options for adults and children with stimulant-induced psychosis associated with ADHD pharmacotherapy.…
Advancing cardiovascular care: how pharmacists are shaping patient outcomes across the UK The UKCPA share some examples to illustrate the breadth and depth of modern cardiovascular pharmacy practice across the UK.…
NICE approves seladelpar for primary biliary cholangitis Around 3,700 people in England will be eligible to receive a new treatment that could delay progression of primary biliary cholangitis and reduce itching.…
Early-onset type 2 diabetes mellitus: identification and management An overview of early-onset type 2 diabetes mellitus, including its pathophysiology, diagnosis and management, as well as approaches for younger adults.…
Health news round up: diabetes, vaping and biologics The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Commissioning pharmacies would be ‘most effective way’ to meet weight-loss demand, MPs told Health and Social Care Committee hears that “further and faster” roll-out is required for weight-management service to prevent “two-tier” system between NHS and private patients.…
Treatment for chemotherapy-resistant ovarian cancer approved for NHS use Women with certain gynaecological cancers that have stopped responding to standard chemotherapy can be offered a targeted therapy on the NHS under new NICE guidance.…
